Liu H - Search Results

1

Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer.

Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang H, Wang Y, Song Y. Liu H, et al. J Thorac Dis. 2013 Dec;5(6):783-9. doi: 10.3978/j.issn.2072-1439.2013.12.34. J Thorac Dis. 2013. PMID: 24409356 Free PMC article.

2

[Expression and its clinical significance of HMGA2 in the patients with non-small cell lung cancer.].

Wu Y, Song Y, Liu H. Wu Y, et al. Among authors: liu h. Zhongguo Fei Ai Za Zhi. 2008 Jun 20;11(3):377-81. doi: 10.3779/j.issn.1009-3419.2008.03.005. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20731938 Free article. Chinese.

3

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.

Luo L, Zhang T, Liu H, Lv T, Yuan D, Yao Y, Lv Y, Song Y. Luo L, et al. Among authors: liu h. Med Oncol. 2012 Sep;29(3):1681-6. doi: 10.1007/s12032-011-0085-8. Epub 2011 Oct 13. Med Oncol. 2012. PMID: 21993632

4

Diagnostic efficiency and complication rate of CT-guided lung biopsy: a single center experience of the procedures conducted over a 10-year period.

Yuan DM, Lü YL, Yao YW, Liu HB, Wang Q, Xiao XW, Cao EH, Shi Y, Zhou XJ, Song Y. Yuan DM, et al. Chin Med J (Engl). 2011 Oct;124(20):3227-31. Chin Med J (Engl). 2011. PMID: 22088512

5

Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.

Lv YL, Yuan DM, Wang QB, Zhan P, Luo L, Lv TF, Liu HB, Li YF, Wen J, Song Y. Lv YL, et al. Med Oncol. 2012 Dec;29(4):2633-9. doi: 10.1007/s12032-012-0180-5. Epub 2012 Feb 22. Med Oncol. 2012. PMID: 22354764

6

Chemotherapy plus multitargeted antiangiogenic tyrosine kinase inhibitors or chemotherapy alone in advanced NSCLC: a meta-analysis of randomized controlled trials.

Xiao YY, Zhan P, Yuan DM, Liu HB, Lv TF, Song Y, Shi Y. Xiao YY, et al. Eur J Clin Pharmacol. 2013 Feb;69(2):151-9. doi: 10.1007/s00228-012-1333-3. Epub 2012 Jun 24. Eur J Clin Pharmacol. 2013. PMID: 22729611 Clinical Trial.

7

The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis.

Wu Y, Liu HB, Ding M, Liu JN, Zhan P, Fu XS, Lu G. Wu Y, et al. Mol Biol Rep. 2012 Oct;39(10):9621-8. doi: 10.1007/s11033-012-1827-1. Epub 2012 Jun 24. Mol Biol Rep. 2012. PMID: 22729914

8

Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma: A meta-analysis.

Miao XH, Yao YW, Yuan DM, Lv YL, Zhan P, Lv TF, Liu HB, Song Y. Miao XH, et al. J Thorac Dis. 2012 Jun 1;4(3):265-71. doi: 10.3978/j.issn.2072-1439.2012.05.09. J Thorac Dis. 2012. PMID: 22754665 Free PMC article.

9

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.

Yao Y, Yuan D, Liu H, Gu X, Song Y. Yao Y, et al. Among authors: liu h. Cancer Immunol Immunother. 2013 Mar;62(3):471-9. doi: 10.1007/s00262-012-1347-9. Epub 2012 Sep 18. Cancer Immunol Immunother. 2013. PMID: 22986452 Free PMC article.

10

Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials.

Xiao YY, Zhan P, Yuan DM, Liu HB, Lv TF, Shi Y, Song Y. Xiao YY, et al. Clin Oncol (R Coll Radiol). 2013 Jan;25(1):e7-e15. doi: 10.1016/j.clon.2012.09.005. Epub 2012 Nov 21. Clin Oncol (R Coll Radiol). 2013. PMID: 23177099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95,250 results

Search Page

Filters